We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Reagent Technology Licensed to Olympus Diagnostica

By Labmedica staff writers
Posted on 20 Jan 2005
A worldwide nonexclusive license to new technology for mixing reagents using surface acoustic waves has been granted to Olympus Diagnostica (Hamburg, Germany) by Advalytix AG (Brunnthal, Germany).

Advalytix pioneered the use of surface acoustic waves (SAW) for the manipulation and agitation of small liquid volumes. More...
The waves induce quasi-chaotic streaming patterns that lead to the efficient agitation of liquids with volumes ranging from several hundred microliters down to a few nanoliters. The agitation method is noninvasive and prevents the risks of cross-contamination and carry-over. SAW technology has been commercially available in a hybridization station of Advalytix called SlideBooster, targeted at the research and development market. Now SAW will be introduced to the diagnostics market.

Olympus Diagnostica will integrate the technology into its product line of routine laboratory analyzers. "This technology will enable Olympus Diagnostica to significantly improve the next generation of analyzers,” noted Dr. Helmut Kohler, CEO of Olympus Diagnostica. Olympus Diagnostica is a systems provider for in vitro diagnostics in clinical chemistry, electrophoresis, and transfusion testing. Under the terms of the agreement, Olympus Diagnostica will provide an upfront payment, milestone payments, and royalties on the sales of instruments.



Related Links:
Olympus Diagnostica
Advalytix

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.